Biopharmaceutical Testing Services | Charles River

bioassays 

Charles River Biopharmaceutical Services (BPS) has the capability to perform a comprehensive array of both in vitro and in vivo bioassays for a variety of biologically active molecules. Bioassays are used to determine the potency or biological activity of a biopharmaceutical. They can be used to assess the potency of proteins, antibodies or hormones by comparing their effects on a culture of living cells or a test organism to those of a control preparation. Potency assays are conducted to determine the activity of the molecule and are regularly part of the regulatory submission and lot release. The concentration or potency of a substance is determined by measurement of the biological response that it produces. The data generated by bioassays are typically analyzed using biostatistical methods.

  • Bioassays are critical for:
    • Product development and manufacturing
    • Ensuring continued quality, safety and efficacy of biopharmaceutical products
  • Bioassays must be:
    • Relevant (reflecting the mode of action of the biopharmaceutical)
    • Reliable
    • Standardized in regards to equipment, materials and procedures
  • According to the European Pharmacopoeia (EP), in vivo assays should be replaced by in vitro assays or physico-chemical methods whenever possible.
  • Several cell-based bioassays are specified in the EP, which are performed following a monograph.
  • Bioassays should be cGMP-compliant.


Assay Types (In Vitro)

  • Cell-based potency assays for EPO, PTH, G-CSF and GM-CSF, and other proteins
  • Antiviral cell-based assays for measuring the potency of interferons (IFN-α, IFN-β)
  • Reporter gene
    • Luminescence
    • Fluorescence
  • Monoclonal antibodies
    • Binding
    • Potency
  • Cytotoxicity
    • Antibody-dependent cell-mediated cytotoxicity 
    • Complement-dependent cytotoxicity
  • Cell proliferation
  • Cell survival
  • Competitive


Statistical Evaluation

  • EC50 determination
  • Four-parameter fit
  • Five-parameter fit
  • Parallel line analysis


For more information, please contact us at askcharlesriver@crl.com.

 

Discover the full range of Charles River Products and Services

For more information please call:

+44 (0) 1875 614545
askcharlesriver@crl.com

view all
This webinar focused on the regulatory requirements for viral clearance studies as well as the influence of various other factors relevant to designing these studies.

News & Events

view all
août 06 - Harmonized Clinical Sample Kits f...
juil. 29 - CR and WuXi Terminate Agreement
sept. 08-sept. 11 - Kyoto, Japan - 2010 World Molecular Imaging Congress
sept. 13-sept. 15 - San Diego, CA, USA - 16th Annual Symposium on Biotechnology-Derived...
sept. 08-sept. 08 - Frankfurt, Germany - Seminar: "Anatomy of the Metabolic Syndrome"
view all
Clinical Pathology Analyst Tranent, Scotl...
Health & Safety Officer Tranent, Scotland

Charles River Laboratories, Inc.